ID bio & H2B

Novacap strengthens its Cosmetics and Healthcare offering with the acquisition of ID bio, a manufacturer of botanical ingredients and H2B, a manufacturer of ingredients for in vitro diagnosis.


ID bio is a biotechnology firm, specialising since 1993 in the extraction, fractionation and purification of botanical substances for the cosmetics industry. This core know-how allows the company to offer botanical ingredients developed with rigorous procedures. ID bio offers a large range of botanical extracts, titrated extracts and active ingredients with applications in hair, make-up and care products.

H2B is specialised in the manufacturing of fractionated blood products for in vitro diagnosis. With over 20 years of experience, the firm has become an expert in fractionation, extraction and purification of animal and human proteins. H2B has developed two different product ranges from bovine plasma and, since 2009, from human plasma so as to meet new market expectations.

ID bio and H2B have also been awarded ISO 9001 and ISO 14001 certifications for their commitment to quality – security – environment culture.

Read the press release